Complex haplotypic structure of the central MHC region flanking TNF in a West African population

Genes and Immunity

Volumn 4, Issue 7, 2003, Pages 476-486

  Ackerman, H C ^a,g,h   Ribas, G ^b   Jallow, M ^d   Mott, R ^a   Neville, M ^c   Sisay Joof, F ^e   Pinder, M ^e   Campbell, R D ^f   Kwiatkowski, D P ^a,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Fund Ctro Nac de Invest Oncol   (Spain)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d Royal Victoria Teaching Hospital Gambia   (Gambia)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f MRC UK HGMP Resource Centre   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h NONE   (United States)

Author keywords

Association; Disequilibrium; Haplotype; Haplotype tagging; htSNP; Linkage; Power

Indexed keywords

DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GAMBIA; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; ENTROPY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MAJOR HISTOCOMPATIBILITY COMPLEX;

ADULT; ALLELES; ENTROPY; FEMALE; GAMBIA; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242670468     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364008     Document Type: Article

References (47)

1. The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 921-923.
2. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264.
3. Conway DJ, Holland MJ, Bailey RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997; 65: 1003-1006.
4. Dunstan SJ, Stephens HA, Blackwell JM et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001; 183: 261-268.
5. Fernandez-Arquero M, Arroyo R, Rubio A et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999; 53: 1361-1363.
6. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
7. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999; 111: 290-298.
8. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
9. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179: 287-290.
10. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.
11. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-880.
12. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999; 117: 1062-1068.
13. Richardson A, Sisay-Joof F, Ackerman H ef al. Nucleotide diversity of the TNF gene region in an African village. Genes Immun 2001; 2: 343-348.
14. Udalova IA, Richardson A, Denys A et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000; 20: 9113-9119.
15. Ackerman H, Usen S, Mott R et al. Haplotypic analysis of the TNF locus by association efficiency and etropy. Genome Biology 2002; 4: R24 http://genomebiology.com/2003/4/4/R24
16. Nordborg M, Tavare S. Linkage disequilibrium: what history has to tell us. Trends Genet 2002; 18: 83-90.
17. Thompson EA, Neel JV. Allelic disequilibrium and allele frequency distribution as a function of social and demographic history. Am J Hum Genet 1997; 60: 197-204.
18. Reich DE, Cargill M, Bolk S et al. Linkage disequilibrium in the human genome. Nature 2001; 411: 199-204.
19. Ribas G, Neville MJ, Campbell RD. Single-nucleotide polymorphism detection by denaturing high-performance liquid chromatography and direct sequencing in genes in the MHC class III region encoding novel cell surface molecules. Immunogenetics 2001; 53: 369-381.
20. Fleiss JL. Statistical Methods for Rates and Proportions. Wiley: New York, 1981; pp. 38-42.
21. Rioux JD, Daly MJ, Silverberg MS et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
22. Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
23. Hull J, Ackerman H, Isles K et al. Unusual haplotypic structure of il8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 2001; 69: 413-419.
24. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
25. Zhang K, Deng M, Chen T, Waterman MS, Sun F. A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 2002; 99: 7335-7339.
26. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650-654.
27. Sabeti PC, Reich DE, Higgins JM et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 2002; 419: 832-837.
28. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
29. Newton CR, Graham A, Heptinstall LE et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-2516.
30. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
31. Nei M. Molecular Evolutionary Genetics. Columbia University Press: New York, 1987; 176-181.
32. Nei M, Roychoudhury AK. Sampling variances of heterozygosity and genetic distance. Genetics 1974; 76: 379-390.
33. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A Software for Population Genetics Analysis. Genetics and Biometry Laboratory, University of Geneva: Switzerland, 2000.
34. Autieri MV, Agrawal N. IRT-1, a novel interferon-gamma-responsive transcript encoding a growth-suppressing basic leucine zipper protein. J Biol Chem 1998; 273: 14731-14737.
35. Neville MJ, Campbell RD. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC. J Immunol 1999; 162: 4745-4754.
36. Holzinger J, de Baey A, Messer G, Kick G, Zwierzina H, Weiss EH. Cloning and genomic characterization of LST1: a new gene in the human TNF region. Immunogenetics 1995; 42: 315-322.
37. Rollinger-Holzinger I, Eibl B, Pauly M et al. LST1: a gene with extensive alternative splicing and immunomodulatory function. J Immunol 2000; 164: 3169-3176.
38. Neville MJ, Campbell RD. Alternative splicing of the LST-1 gene located in the Major Histocompatibility Complex on human chromosome 6. DNA Seq 1997; 8: 155-160.
39. Browning JL, Ngam-ek A, Lawton P et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993; 72: 847-856.
40. Nakamura T, Tashiro K, Nazarea M, Nakano T, Sasayama S, Honjo T. The murine lymphotoxin-beta receptor cDNA: isolation by the signal sequence trap and chromosomal mapping. Genomics 1995; 30: 312-319.
41. Nedospasov SA, Shakhov AN, Turetskaya RL et al. Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome. Cold Spring Harbor Symp Quant Biol 1986; 51(Part 1): 611-624.
42. Old LJ. Tumor necrosis factor (TNF). Science 1985; 230: 630-632.
43. Gray PW, Aggarwal BB, Benton CV et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 1984; 312: 721-724.
44. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985; 318: 665-667.
45. Albertella MR, Campbell RD. Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Hum Mol Genet 1994; 3: 793-799.
46. Peelman LJ, Chardon P, Nunes M et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family. Genomics 1995; 26: 210-218.
47. Fleckner J, Zhang M, Valcarcel J, Green MR. U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev 1997; 11: 1864-1872.